tag:blogger.com,1999:blog-9002218232182793493.post9110544800002457026..comments2024-03-28T01:14:05.420-07:00Comments on PharmaLittle: MORE NUANCED DISCUSSION OF BIOLOGICS AND EXCLUSIVITYUnknownnoreply@blogger.comBlogger1125tag:blogger.com,1999:blog-9002218232182793493.post-21929928925509909922009-07-23T09:43:16.970-07:002009-07-23T09:43:16.970-07:00While reading the link, all I could think of is th...While reading the link, all I could think of is that the promise of needed medication is being smashed by greed. <br /><br />“At issue are such drugs as Biogen Idec’s Avonex, for multiple sclerosis, which can cost more than $20,000 a year; Genentech’s Avastin for cancer, which can cost more than $50,000; and several Genzyme drugs for rare diseases that can cost $200,000 a year or more.”<br /><br />These meds will definitely be reserved for the very rich whose insurance plans cover the drugs and who can afford the co-pays. Most patients in need will be left out. Is this really the best America can do?Michaelnoreply@blogger.com